Bio-Rad Laboratories, Inc. (BIO) — Fair Value Analysis

Base-case fair value (P50): $339.75 · Current price: $325.48 · Verdict: Fairly Valued

The Verdict on BIO

Based on Monte Carlo simulations, BIO RAD LABORATORIES INC CLASS A (BIO) is currently Fairly Valued. While the current price of $325.48 sits below our P50 median fair value of $339.75, indicating a potential +4.4% upside, the probabilistic distribution suggests the stock is adequately priced within its expected range. This assessment factors in thousands of simulated future scenarios to determine a robust fair value, positioning BIO as neither significantly overvalued nor undervalued at its current trading level. Investors should consider this balanced perspective when evaluating BIO's near-term potential against our $339.75 target.

How BIO stacks up against peers

BIO's quality tier is assessed as average in terms of its operational and financial health compared to its sector peers. This indicates a solid but not exceptional standing, contributing to its "Fairly Valued" verdict despite the +4.4% gap to our $339.75 median fair value. While the stock trades at $325.48, its fundamental characteristics suggest a performance in line with its industry. An average quality tier implies that while there are no immediate red flags, there isn't a strong fundamental advantage compelling a substantial premium or discount relative to the $339.75 fair value estimate.

What this means for investors

For investors tracking BIO, the current trading price of $325.48 against a median fair value of $339.75 suggests a modest +4.4% opportunity, aligning with a "Fairly Valued" assessment. The average quality tier reinforces the expectation of stable, rather than explosive, performance. While our simulations reveal potential upside, prudent investors will recognize that this stock currently sits comfortably within its fair value band. To understand the full range of possibilities, including specific bear-case and bull-case scenarios and the probability of reaching our price targets, sign up for a free FairCurve account.